Deep phenotyping in 3q29 deletion syndrome: recommendations for clinical care.
Deep phenotyping in 3q29 deletion syndrome: recommendations for clinical care.
复制标题
DOI:
10.1038/s41436-020-01053-1
复制
发表时间:
2021-05
期刊:
影响因子:
--
通讯作者:
Mulle JG
中科院分区:
文献类型:
--
作者:
Sanchez Russo R;Gambello MJ;Murphy MM;Aberizk K;Black E;Burrell TL;Carlock G;Cubells JF;Epstein MT;Espana R;Goines K;Guest RM;Klaiman C;Koh S;Leslie EJ;Li L;Novacek DM;Saulnier CA;Sefik E;Shultz S;Walker E;White SP;Emory 3q29 Project;Mulle JG
To understand the consequences of the 3q29 deletion on medical, neurodevelopmental, psychiatric, brain structural, and neurological sequalae by systematic evaluation of affected individuals. To develop evidence-based recommendations using these data for effective clinical care. Thirty-two individuals with the 3q29 deletion were evaluated using a defined phenotyping protocol and standardized data collection instruments. Medical manifestations were varied and reported across nearly every organ system. The most severe manifestations were congenital heart defects (25%) and the most common were gastrointestinal symptoms (81%). Physical examination revealed a high proportion of musculoskeletal findings (81%). Neurodevelopmental phenotypes represent a significant burden and include intellectual disability (34%), autism spectrum disorder (38%), executive function deficits (46%), and graphomotor weakness (78%). Psychiatric illness manifests across the lifespan with psychosis prodrome (15%), psychosis (20%), anxiety disorders (40%), and attention deficit–hyperactivity disorder (ADHD) (63%). Neuroimaging revealed structural anomalies of the posterior fossa, but on neurological exam study subjects displayed only mild or moderate motor vulnerabilities. By direct evaluation of 3q29 deletion study subjects, we document common features of the syndrome, including a high burden of neurodevelopmental and neuropsychiatric phenotypes. Evidence-based recommendations for evaluation, referral, and management are provided to help guide clinicians in the care of 3q29 deletion patients.
登录
查看更多内容
影响因子:
2.4
作者:
Hill DA;Grundmeier RW;Ram G;Spergel JM
通讯作者:
Spergel JM
影响因子:
4.4
作者:
Murphy, Melissa M.;Burrell, T. Lindsey;Mulle, Jennifer Gladys
通讯作者:
Mulle, Jennifer Gladys
影响因子:
8
作者:
Zablotsky, Benjamin;Black, Lindsey, I;Boyle, Coleen A.
通讯作者:
Boyle, Coleen A.
影响因子:
14.2
作者:
Dykewicz, Mark S.;Hamilos, Daniel L.
通讯作者:
Hamilos, Daniel L.
影响因子:
6.6
作者:
Charlson, Fiona J.;Ferrari, Alize J.;Whiteford, Harvey A.
通讯作者:
Whiteford, Harvey A.